Señales en vivo de RAC.AX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 02:10):

Stats
Volumen de hoy	21 196.00
Volumen promedio	149 809
Capitalización de mercado	197.81M
EPS	$0 ( 2024-02-25 )
Próxima fecha de ganancias	( $0 ) 2024-07-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-17.00
ATR14	$0.0150 (1.28%)

Race Oncology Ltd Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Race Oncology Ltd Correlación - Moneda/Commodity

-0.43
( neutral )

-0.13
( neutral )

0.00
( neutral )

-0.49
( neutral )

0.41
( neutral )

Race Oncology Ltd Finanzas

Annual	2023
Ingresos:	$3.13M
Beneficio Bruto:	$2.85M (91.03 %)
EPS:	$-0.0617

FY	2023
Ingresos:	$3.13M
Beneficio Bruto:	$2.85M (91.03 %)
EPS:	$-0.0617

FY	2022
Ingresos:	$707 807
Beneficio Bruto:	$426 611 (60.27 %)
EPS:	$-0.0731

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.0794

Financial Reports:

No articles found.

Race Oncology Ltd

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.